Compare Tivicay vs. Genvoya
Head-to-head comparisons of medication uses, side effects, ratings, and more.
Works with other medicines to treat HIV infection.
Tivicay (dolutegravir) is currently one of the top choices in its drug class to be used in treating HIV infectons.
Treats HIV infection.
Genvoya (elvitegravir / cobicistat / emtricitabine / tenofovir) is a convenient 4-in-1 medication. It's one of the first choices used to treat HIV infections and contains a newer medication that's safer for your kidneys and bones.
Upsides
- First-line treatment for preventing HIV infection in combination with other HIV medications.
- There is less resistance to Tivicay (dolutegravir) compared to other drugs in its class.
- Can be taken with or without food.
- Tivicay (dolutegravir) has very few interactions with other drugs.
- Can be taken by children weighing at least 30kg (66lbs).
- First-choice treatment for HIV infections.
- One tablet contains four different HIV medications and is only taken once daily.
- Genvoya (elvitegravir / cobicistat / emtricitabine / tenofovir) has fewer side effects (headache, nausea, fatigue, diarrhea), and is safer on your kidneys and bones than Stribild.
Downsides
- Has to be taken at the same time(s) every day or your body can become resistant to the medication.
- Can't be taken on its own to treat HIV.
- Can cause changes in how fat is dsitributed in your body
- Should be taken with food.
- Can increase cholesterol levels.
- Can interact with many other drugs.
Used for
- HIV infection
- HIV prevention
Dosage forms
- Pill
- Pill
Price
Lowest price
$2003.50
Find instant savings near youLowest price
$3564.91
Find instant savings near youWant to save even more money?
Sign up now for a 30-day trial and save up to 95% at CVS, Kroger, Albertsons, and other pharmacies.
Learn more
Reviews
Not enough review data.Leave a review
Not enough review data.Leave a review
Side effects
Risks and risk factors
- Allergic reactions
- Prior severe allergic reaction to Tivicay (dolutegravir) or any of its individual drug components.
- Immune reconstitution syndrome
- HIV
- Exposure to other infections
- Start of a new HIV medication
- Change in HIV therapy
- Increased liver function tests
- History of liver disease
- Hepatitis B or C infection
- Fat redistribution
- HIV treatment
- Lactic acidosis | Enlarged, fatty liver
- Liver disease
- Women
- Obesity
- Worsening hepatitis B infection
- Hepatitis B Virus infection
- Kidney damage
- History of kidney damage
- Taking other medicines that can harm the kidneys
- Immune reconstitution syndrome
- HIV
- Exposure to other infections
- Start of a new HIV medication
- Change in HIV therapy
- Drug interactions
- Taking medicines that interact with Genvoya (elvitegravir / cobicistat / emtricitabine / tenofovir)